Ionetix

About Ionetix

Ionetix leverages its proprietary cyclotron and accelerator expertise to produce a growing portfolio of critical medical isotopes for diagnostic imaging and targeted alpha therapy. For diagnostics, Ionetix manufactures Positron Emission Tomography (PET) radiopharmaceuticals through its network of FDA-approved sites close to the point of care. These agents are used in imaging for a variety of medical conditions, including cardiology, oncology and neurology. For therapeutics, Ionetix is focused on producing high-purity, alpha-emitting therapeutic isotopes, including actinium-225 and astatine-211. Ionetix is also exploring additional applications for its particle accelerator technology beyond isotope production. Ionetix is headquartered in Lansing, Michigan. For more information, please visit www.ionetix.com.